Home » Newsletters » BioWorld Science

BioWorld Science

March 17, 2021

View Archived Issues

Linking antiphospholipid antibodies to autoimmunity

Lipid dysregulation gives information on Parkinson's

Immune system, treatment, in kidney cancer

Moderna initiates phase I study of its next-generation COVID-19 vaccine, mRNA-1283

Multimorbid diseases cluster in predictable ways: study

Pliant completes phase I study of PLN-1474 and transfers the candidate to Novartis

First patients dosed in global phase I study of ADG-126

First patient dosed in phase I study of emricasan in mild symptomatic COVID-19

Arbutus receives regulatory approval for phase Ia/Ib trial of AB-836 in chronic HBV infection

Galmed initiates dosing in first-in-human phase I trial of Amilo-5MER

FDA clears IND for phase II study of CYTO-205 as treatment of mild COVID-19

AB-205 eliminates oral and gastrointestinal SRRT in adults undergoing HDT-AHCT

UCB describes new antimalarial compounds

KalVista Pharmaceuticals discovers FXIIa inhibitors

Otsuka Pharmaceutical, Taiho Pharmaceutical patent PTPN11 inhibitors

New anti-SIRP-alpha antibodies described by Elpiscience BioPharma

First-in-human results presented for R-552 in healthy adults

Biohaven Therapeutics identifies compounds targeting TDP-43

Study reveals dose finding for gevokizumab in oncology

THCVHS shows no signs of eye irritation in in vitro assay

French clearance for first-in-human study of PEP-010 in advanced solid tumors

Phase Ib data with VS-01 support advancement to phase IIa for acute on chronic liver failure

Corat gains clearances to begin phase Ib/II trial of COR-101 for COVID-19

HTI vaccines show promise for virus control without ART in patients with early HIV infection

Clinical trial collaboration supports new phase II study of Tabrecta and Nerlynx in breast cancer

Annovis reports phase IIa interim data on ANVS-401 in Parkinson's patients

MaaT reports phase II topline data on MaaT-013 in steroid-refractory GI acute GvHD

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...